Organization Overview
Historical Acquisition Tree
Alternative names
Key: Novo Nordisk (30) Acquired (4)
antihemophilic factor viii (Recombinant) (Adynovate) (2013)
bacitracin (polysporin) (2014)
caspofungin (cancidas) (2018)
coagulation factor ix (Recombinant) (Rixubis) (2017)
coagulation factor viia (recombinant) (NovoSevenRT) (1999 NDA)
coagulation factor xiii a-subunit (recombinant) (Tretten) (2013 NDA)
colistin (2015)
daptomycin (cubicin) (2017)
estradiol (progynon depot) (1999)
glucagon (1998)
insulin aspart (Novolog) (2008 NDA)
Insulin, bovine (1980)
insulin degludec (tresiba) (2015 NDA)
insulin detemir (Levemir) (2005 NDA)
insulin human (humulin) (1983)
insulin lispro (humalog) (2000)
Insulin, porcine (1980)
liraglutide (victoza) (2010 NDA)
macimorelin (Macrilen) (2017)
metformin (glucophage) (2008)
micafungin (mycamine) (2021)
nedosiran (rivfloza) (2023 NDA)
norethindrone (2000)
polymyxin b sulfate (poly-rx) (2014)
protamine insulin (1980)
repaglinide (prandin) (2008)
semaglutide (Ozempic) (2017 NDA)
somapacitan (Sogroya) (2020 NDA)
somatropin (protropin) (1995)
tigecycline (tygacil) (2019)
tobramycin (nebcin) (2014)
vancomycin (Vancocin) (2019)
voriconazole (vfend) (2017)
Key: Novo Nordisk (56) Acquired (5)
antihemophilic factor viii human (Hemofil M) (1 trial)
anti-inhibitor coagulant complex (activated prothrombin complex concentrate) (Autoplex-T) (1 trial)
attenuated measles vaccine - Edmonston strain (rubeovax) (3 trials)
bupropion (wellbutrin) (2 trials)
coagulation factor viia (recombinant) (NovoSevenRT) (41 trials)
colchicine (colbenemid) (1 trial)
dapagliflozin (farxiga) (3 trials)
dicloxacillin (pathocil) (1 trial)
dulaglutide (trulicity) (3 trials)
empagliflozin (jardiance) (5 trials)
glimepiride (amaryl) (16 trials)
glyburide (micronase) (5 trials)
human coagulation factor ix (Mononine) (1 trial)
hyaluronidase (human recombinant) (Hylenex) (1 trial)
hydralazine (apresoline) (1 trial)
insulin aspart (Novolog) (18 trials)
insulin degludec (tresiba) (125 trials)
insulin detemir (Levemir) (94 trials)
insulin glargine (toujeo) (95 trials)
insulin human (humulin) (109 trials)
lixisenatide (adlyxin) (1 trial)
metformin (glucophage) (5 trials)
metoprolol (lopressor) (1 trial)
nateglinide (starlix) (1 trial)
nebivolol (bystolic) (1 trial)
Key: Novo Nordisk (15) Acquired (8)
calcitriol (rocaltrol) (8 trials)
canagliflozin (invokana) (1 trial)
Key: Novo Nordisk (35) Acquired (26)
acetaminophen (tylenol) (3 trials)
autologous platelets (1 trial)
azacitidine (vidaza) (2 trials)
becaplermin (regranex) (1 trial)
budesonide (rhinocort) (1 trial)
cedazuridine (Inqovi) (1 trial)
dobutamine (dobutrex) (1 trial)
evolocumab (repatha) (1 trial)
gemcitabine (gemzar) (2 trials)
growth hormone (Protropin) (1 trial)
heat-labile enterotoxin of e. coli (1 trial)
Key: Novo Nordisk (49) Acquired (62)
acetylcysteine (mucomyst) (1 trial)
albumin (Human) (Plasbumin) (1 trial)
albuterol (proventil) (1 trial)
antihemophilic factor viii (Recombinant) (Adynovate) (1 trial)
atorvastatin (lipitor) (2 trials)
bevacizumab (avastin) (1 trial)
candesartan (atacand) (1 trial)
clopidogrel (plavix) (2 trials)
coagulation factor ix (Recombinant) (Rixubis) (1 trial)
coagulation factor ix (Recombinant), Fc-fusion protein (Alprolix) (1 trial)
coagulation factor xiii a-subunit (recombinant) (Tretten) (1 trial)
cromoglicic acid (Intal) (1 trial)
diltiazem (cardizem) (1 trial)
elsulfavirine (Elpida) (1 trial)
ethinyl estradiol (Estinyl) (4 trials)
fluconazole (diflucan) (1 trial)
fruquintinib (Fruzaqla) (2 trials)
griseofulvin (grisactin) (1 trial)
hydrochlorothiazide (esidrix) (1 trial)
inactivated influenza vaccine (2 trials)
insulin glulisine (Apidra) (1 trial)
itraconazole (sporanox) (2 trials)
levothyroxine (Synthroid) (1 trial)
lisinopril (zestril) (2 trials)
live attenuated influenza virus vaccine (Flumist) (1 trial)
olmesartan (benicar) (2 trials)
omaveloxolone (SKYCLARYS) (1 trial)
omeprazole (prilosec) (1 trial)
probenecid (colbenemid) (1 trial)
propafenone (rythmol) (1 trial)
rabeprazole (pariet) (2 trials)
rosuvastatin (crestor) (1 trial)
telmisartan (micardis) (1 trial)
trans sodium crocetinate (1 trial)
trastuzumab (herceptin) (1 trial)
vancomycin (Vancocin) (1 trial)
Key: Novo Nordisk (17) Acquired (2)
Adrenal Insufficiency (Phase 4)
Aging, Premature (Phase 4)
Albuminuria (Phase 4)
Anorexia (Phase 3)
Anorexia Nervosa (Phase 3)
Apnea (Phase 3)
Arteriosclerosis (Phase 4)
Arthritis (Phase 2)
Arthritis, Psoriatic (Phase 2)
Arthritis, Rheumatoid (Phase 2)
Asthma (Phase 3)
Atherosclerosis (Phase 4)
Athletic Injuries (Phase 2)
Atrophic Vaginitis (Phase 4)
Atrophy (Phase 4)
Binge-Eating Disorder (Phase 3)
Bipolar Disorder (Phase 2)
Blood Coagulation Disorders (Phase 4)
Body Weight (Phase 3)
Body Weight Changes (Phase 4)
Bone Diseases, Metabolic (Phase 3)
Brain Concussion (Phase 2)
Brain Injuries (Phase 2)
Brain Injuries, Traumatic (Phase 2)
Bulimia (Phase 3)
Carcinoma (Phase 2)
Carcinoma, Ovarian Epithelial (Phase 2)
Carcinoma, Renal Cell (Phase 2)
Cardiovascular Diseases (Phase 4)
Cerebral Hemorrhage (Phase 3)
Chemical and Drug Induced Liver Injury (Phase 1)
Communicable Diseases (Phase 3)
Critical Illness (Phase 2)
Crohn Disease (Phase 2)
Cystic Fibrosis (Phase 3)
Cystitis (Phase 2)
Dengue (Phase 2)
Depression (Phase 2)
Diabetes Complications (Phase 4)
Diabetes, Gestational (Phase 4)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 1 (Phase 4)
Diabetes Mellitus, Type 2 (Phase 4)
Diabetic Nephropathies (Phase 4)
Diabetic Neuropathies (Phase 4)
Digestive System Diseases (Phase 1)
Diphtheria (Phase 4)
Disease (Phase 3)
Dwarfism (Phase 3)
Dwarfism, Pituitary (Phase 4)
Dysbiosis (Phase 4)
Emergencies (Phase 4)
Endocrine System Diseases (Phase 4)
Fatty Liver (Phase 4)
Feeding and Eating Disorders (Phase 3)
Fetal Growth Retardation (Phase 4)
Fever (Phase 2)
Fibrosis (Phase 3)
Fractures, Bone (Phase 2)
Gastrointestinal Diseases (Phase 1)
Genetic Diseases, Inborn (Phase 4)
Glucose Intolerance (Phase 3)
Gonadal Dysgenesis (Phase 4)
Growth Disorders (Phase 3)
Heart Diseases (Phase 3)
Heart Failure (Phase 4)
Hematoma (Phase 2)
Hemophilia A (Phase 4)
Hemophilia B (Phase 4)
Hemorrhage (Phase 4)
Hemorrhagic Disorders (Phase 1)
Hemorrhagic Fevers, Viral (Phase 2)
Hemostatic Disorders (Phase 4)
HIV Infections (Phase 4)
Hypercholesterolemia (Phase 1)
Hyperglycemia (Phase 4)
Hypertension (Phase 4)
Hypoglycemia (Phase 4)
Hypopituitarism (Phase 2)
Hypoxia (Phase 4)
Infarction (Phase 4)
Infections (Phase 3)
Inflammation (Phase 2)
Insulin Resistance (Phase 4)
Kidney Diseases (Phase 4)
Kidney Failure, Chronic (Phase 4)
Leukemia (Phase 3)
Leukemia, Lymphoid (Phase 3)
Liver Cirrhosis (Phase 2)
Liver Diseases (Phase 4)
Lung Diseases (Phase 3)
Lung Diseases, Obstructive (Phase 3)
Lupus Erythematosus, Systemic (Phase 1)
Lymphoma (Phase 3)
Measles (Phase 4)
Melanoma (Phase 2)
Metabolic Syndrome (Phase 4)
Mood Disorders (Phase 2)
Muscular Atrophy (Phase 2)
Muscular Atrophy, Spinal (Phase 2)
Myocardial Infarction (Phase 4)
Non-alcoholic Fatty Liver Disease (Phase 4)
Non-ST Elevated Myocardial Infarction (Phase 4)
Noonan Syndrome (Phase 3)
Nutrition Disorders (Phase 3)
Obesity (Phase 4)
Obesity, Abdominal (Phase 4)
Osteoporosis (Phase 4)
Ovarian Neoplasms (Phase 2)
Overweight (Phase 4)
Parkinson Disease (Phase 2)
Peripheral Arterial Disease (Phase 3)
Peripheral Vascular Diseases (Phase 3)
Polycystic Ovary Syndrome (Phase 3)
Prader-Willi Syndrome (Phase 4)
Prediabetic State (Phase 3)
Premenstrual Dysphoric Disorder (Phase 4)
Premenstrual Syndrome (Phase 4)
Psoriasis (Phase 2)
Puberty, Delayed (Phase 3)
Pulmonary Disease, Chronic Obstructive (Phase 3)
Renal Insufficiency (Phase 4)
Renal Insufficiency, Chronic (Phase 4)
Sepsis (Phase 3)
Severe Dengue (Phase 2)
Shock (Phase 3)
Shock, Septic (Phase 3)
Sleep Apnea, Obstructive (Phase 3)
Sleep Apnea Syndromes (Phase 3)
ST Elevation Myocardial Infarction (Phase 4)
Syndrome (Phase 4)
Tetanus (Phase 4)
Thrombasthenia (Phase 1)
Tibial Fractures (Phase 2)
Tobacco Use Disorder (Phase 2)
Toxemia (Phase 3)
Turner Syndrome (Phase 4)
Urinary Tract Infections (Phase 3)
Vaginitis (Phase 4)
Weight Loss (Phase 4)
Whooping Cough (Phase 4)
Wounds and Injuries (Phase 3)